Research & Development
MC3 unveils US FDA approved Crescent Jugular Dual Lumen Catheter for ECMO (Extracorporeal membrane oxygenation) indication in the US
19 October 2018 -

Medical device company MC3 Cardiopulmonary reported on Thursday the availability of the US FDA approved Crescent Jugular Dual Lumen Catheter for ECMO (Extracorporeal membrane oxygenation) indication in patients with acute respiratory failure in the US.

The company added the Crescent catheter is placed through the jugular vein and is connected to an ECMO system, which removes carbon dioxide and reinfuses oxygenated blood.

According to the company, the Crescent Jugular Dual Lumen Catheter is a single use dual lumen catheter, which provides both venous drainage and re-infusion of blood via the jugular vein, that is indicated for use in patients with acute respiratory failure requiring Veno-Venous Extracorporeal Membrane Oxygenation. where other available treatment options have failed and continued clinical deterioration is expected or the risk of death is imminent.

Crescent's unique design permits unmatched flow performance, minimises re-circulation and enables smooth insertion, visible location and highly durable placement, concluded the company.

Login
Username:

Password: